Sebastien Eymere

Putnam, 207 Rue De Bercy
Paris, 75012, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan.

Correction: Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan.

Journal: Breast cancer (Tokyo, Japan)

Published: August 21, 2026

Clinical and economic benefits of combined genetic and genomic testing strategies to guide treatment decisions for patients with HR+/HER2- breast cancer in the US.

Clinical and economic benefits of combined genetic and genomic testing strategies to guide treatment decisions for patients with HR+/HER2- breast cancer in the US.

Journal: Journal of medical economics

Published: February 19, 2026

Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.

Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.

Journal: Ophthalmology and therapy

Published: October 23, 2025

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan.

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan.

Journal: Breast cancer (Tokyo, Japan)

Published: July 31, 2025

Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France.

Cost-Effectiveness and Public Health Impact of Newborn Screening for Spinal Muscular Atrophy in France.

Journal: Applied health economics and health policy

Published: July 25, 2025

Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares.

Cost-Effectiveness Analysis of Influenza Treatments in Japan Using a Transmission Model: The Impact of Baloxavir and Oseltamivir Shares.

Journal: Infectious diseases and therapy

Published: April 15, 2025

Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan.

Cost-Effectiveness and Public Health Impact of Universal Prophylaxis with Nirsevimab Against Respiratory Syncytial Virus (RSV) Infections in all Infants in Japan.

Journal: Infectious diseases and therapy

Published: October 22, 2024

Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.

Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.

Journal: Acta dermato-venereologica

Published: July 07, 2021

Realist protocol for implementing integrated care pathways in France (waiver 51 LFSS 2018)

Realist protocol for implementing integrated care pathways in France (waiver 51 LFSS 2018)

Journal: Annales pharmaceutiques francaises

Published: April 15, 2021

Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis.

Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis.

Journal: Clinical, cosmetic and investigational dermatology

Published: September 01, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026